GenePOC: Cincinnati public company could pay $120M for Canadian firm

One of Greater Cincinnati's largest public companies is planning an acquisition that could have a price tag of up to $120 million. Meridian Bioscience (Nasdaq: VIVO) has agreed to acquire Quebec City-based GenePOC Inc. The Newtown-based maker of clinical diagnostic test kits will pay $50 million in cash for the Canadian company when the deal closes along with up to $70 million in additional payments conditional upon certain technical development milestones and sales thresholds. GenePOC has about...